Prognostic index models in stage I and II endometrial carcinoma

Anticancer Research

Volumn 18, Issue 5 B, 1998, Pages 3717-3724

  Nordström, Britta ^a   Bergström, Reinhold ^b   Strang, Peter ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Endometrial carcinoma; Flow cytometry; Multivariate analysis; Prognosis; Prognostic index

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; CONTROLLED STUDY; DIFFERENTIATION; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 0031647379     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Stendahl U, Eklund G, Willen H and Willén R: Invasive squamous cell carcinoma of the uterine cervix. III. A malignancy grading system for indication of prognosis after radiation therapy. Acta Radiol Oncol 20: 231-243, 1981.
2. Jakobsson P, Eneroth C-M, Killander D, Moberger G and Martensson B. Histologic classification and grading of malignancy in carcinoma of larynx. Acta Radiol Oncol 12: 1-8, 1973.
3. Simonsson B, Källander CFR, Brenning G, el al: Biochemical markers in multiple myeloma: a multivariate analysis. Br J Haematol 69: 47-53, 1988.
4. Thörn M, Pontén F, Bergström R, Sparén P, Adami H-O: Clinical and histopathological predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst 86: 760-769, 1994.
5. Bergholm U, Adami H-O, Bergström R, et al: Long-term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. Acta Chir Scand 156: 37-46, 1990.
6. Gronowitz JS, Bergström R, Nôu E, et al: Clinical and serologic markers of stage and prognosis in small cell lung cancer. Cancer 66: 722-732, 1990.
7. Wagenius G, Strang P, Bergström R, Stendahl U and Tribukait B: Prognostic indices in endometrial adenocarcinoma stages I and II. A study based on clinical, histopathological and flow cytometric variables. Anticancer Res 11: 2137-2142,1991.
8. FIGO: Classification and staging of malignant tumors in the female pelvis. Int J Gynecol Obstet 9: 172-179, 1971.
9. Poulsen H, Taylor C W, Sobin LH: Histological typing of female genital tract tumors. International Histologic Classification of Tumors. World Health Organization, Geneva 13: 63-73, 1975.
10. Sobin LH, Thomas LB, Constance P and Henson D: A Coded Compendium of International Histological Classification of Tumours (Ed.) Ep. 11. World Health Organization, Geneva, 1978.
11. FIGO stages-1988 revisions: Vulva, ovary, corpus. Gynecol Oncol 35: 125-127, 1989.
12. Rosenberg P, Risberg B, Simonsen E. The prognostic importance of uterine papillary serous carcinoma, FIGO grade, nuclear grade, and age on endometrial carcinoma stage I and II. Acta Obstet Gynecol Scand 68: 157-163, 1989.
13. Tribukait B. Flow cytometry in surgical pathology and cytology of tumors of the genito-urinary tract. In: Advances in clinical cytology. (Koss L, Coleman D, Masson, eds). New York, 1984, Vol. 2, pp 163-189.
14. Heiden T, Strang P, Stendahl U, Tribukait B: Reproducibility of flow cytometric analyses in human malignancies. Anticancer Res 10: 49-54, 1990.
15. Castro J, Heiden T, Wang N, Tribukait B: Preparation of cell nuclei from fresh tissues for high-quality DNA flow cytometry. Cytometry 14:793-804, 1993.
16. Baisch H, Göhde W and Linden W: Analysis of PCP-data to determine the fraction of cells in various phases of cell cycle. Radiat Environ Biophys 12: 31-37, 1975.
17. B Nordström, P Strang, S Nilsson, R Bergstrom, B Tribukait: Ki-67, PCNA, S-phase fraction as Indicators of Proliferation and Prognosis in Carcinoma of the Uterus. Cancer 78/9: 1942-1951, 1996.
18. P Strang, B Nordström, S Nilsson, R Bergström, B Tribukait: p53 Protein-as a Predictor of Survival in Endometrial carcinomas. Eur J Cancer 32A 4: 598-602, 1996.
19. Kjellgren O, Jonsson L: Further development of the Heyman radium packing method. Acta Radiol 3: 143-151, 1964.
20. Lawless JF: Statistical models and methods for life-time data. New York: Wiley, 1982.
21. Connelly PJ, Alberhasky RC, Christopherson WM: Carcinoma of the endometrium III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma. Obstet Gynecol 59: 569-575, 1982.
22. Rosenberg P, Risberg B, Simonsen E: The prognosis in early endometrial carcinoma. The importance of uterine papillary serous carcinoma (UPSC), Age, FIGO grade, and nuclear grade. Acta Obstet Gynecol Scand 68: 157-163, 1989.
23. Sorbe B, Risberg B, Frankendal B: DNA ploidy, morphometry, and nuclear grade as prognostic factors in endometrial carcinomas. Gynecol Oncol 38: 22-27, 1990.
24. Sorbe B, Risberg B, Thornthwaite J: Nuclear morphometry and DNA flow cytometry as prognostic methods for endometrial carcinoma. Int J Gynecol Cancer 4: 94-100, 1994.
25. Stendahl U, Strang P, Wagenius G, Bergström R, Tribukait B. Prognostic significance of proliferation in endometrial adenocarcinomas: A multivariate analysis of clinical and flow cytometric variables. Int J Gynecol Pathol 10: 271-284, 1991.
26. Strang P, Stenkvist B, Bergström R, Stendahl U, Valdes del Campo M, Tribukait B: Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study. Anticancer Res 11: 783-788, 1991.
27. Beckner M, Mori T and Silverberg G: Endometrial carcinoma: Nontumor factors in prognosis. Int J Gynecol Path 4: 131-145, 1985.
28. Nordstroöm B, Strang P, Lindgren A, Bergström R. Tribukait B: Carcinoma of the Endometrium. Does the Nuclear grade and DNA ploidy provide more prognostic information than the FIGO and WHO classifications? Int J Gynecol Path 15, 191-201, 1996.
29. W. Graf, R. Bergström, L Påhlman, B Glimelius: Appraisal of a Model for Prediction of Prognosis in Advanced Colorectal Cancer. Eur J Cancer, Vol 30A, No 4: 453-457, 1994
30. W Graf, R Bergström, L Påhlman, B Glimelius: The relationship between an response to chemotherapy and survival in advanced colorectal cancer. Br J Cancer 70: 559-563 1994.
31. JPA Baak, WP Snijders, PJ Van Diest, E Armee-Horväth and P Kenemans: Confirmation ofthe prognostic value ofthe ECPI-I score (myometrial invasion, DNA-ploidy and mean shortest nuclear axis) in FIGO stage I endometrial cancer patients with long follow-up. Int J Gynecol Cancer 5: 112-116, 1995.